Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression

Journal of Investigative Dermatology

Volumn 127, Issue 10, 2007, Pages 2438-2444

  Pourreyron, Celine ^a   Cox, Georgie ^a,b   Mao, Xin ^a   Volz, Andreas ^d   Baksh, Nuzhat ^a   Wong, Tracy ^a,b   Fassihi, Hiva ^b   Arita, Ken ^b   O'Toole, Edel A ^a   Ocampo Candiani, Jorge ^f   Chen, Mei ^e   Hart, Ian R ^c   Bruckner Tuderman, Leena ^d   Salas Alanis, Julio C ^f   McGrath, John A ^b   Leigh, Irene M ^a   South, Andrew P ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4 ALPHA1 CHAIN; COLLAGEN TYPE 7; UNCLASSIFIED DRUG; DNA;

ADULT; ARTICLE; CANCER SURGERY; CELL CULTURE; CELL LYSATE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMOLYSIS BULLOSA; FEMALE; GENE MUTATION; GENETIC CODE; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECESSIVE INHERITANCE; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING; CELL TRANSFORMATION; EPIDERMOLYSIS BULLOSA DYSTROPHICA; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; ONCOGENE RAS; RISK FACTOR; SKIN TUMOR; STOP CODON;

ADULT; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CODON, NONSENSE; COLLAGEN TYPE VII; DNA, NEOPLASM; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FEMALE; GENE EXPRESSION REGULATION; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; RISK FACTORS; SKIN NEOPLASMS;

EID: 34848914349     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700878     Document Type: Article

References (17)

1. Backvall H, Asplund A, Gustafsson A, Sivertsson A, Lundeberg J, Ponten F (2005) Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma. Mutat Res 571:65-79
2. Bruckner-Tuderman L, Hopfner B, Hammami-Hauasli N (1999) Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa. Matrix Biol 1:43-54
3. Burgeson RE (1993) Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol 101:252-5
4. Chen M, Marinkovich MP, Veis A, Cai X, Rao CN, O'Toole EA et al. (1997) Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin. J Biol Chem 272:14516-22
5. Christiano AM, Anhalt G, Gibbons S, Bauer EA, Uitto J (1994) Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa. Genomics 21:160-8
6. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ et al. (2003) NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421:639-43
7. Fine JD, Johnson LB, Suchindran C, Bauer EA, Carter M, McGuire J et al. (1999) Cancer and inherited epidermolysis bullosa: lifetable analyses of the national epidermolysis bullosa registry study population. In: Fine JD, Bauer EA, McGuire J, Moshell A (eds). Epidermolysis Bullosa. Clinical, Epidemiologic and Laboratory Advances and the Findings of the National Epidermolysis Bullosa Registry. Baltimore: The Johns Hopkins University Press, 175-92
8. Jarvikallio A, Pulkkinen L, Uitto J (1997) Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1). Hum Mutat 10:338-47
9. Kern JS, Kohlhase J, Bruckner-Tuderman L, Has C (2006) Expanding the COL7A1 mutation database: novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa. J Invest Dermatol 126:1006-12
10. Mallipeddi R (2002) Epidermolysis bullosa and cancer. Clin Exp Dermatol 27:616-23
11. McGrath JA, Ishida-Yamamoto A, O'Grady A, Leigh IM, Eady RA (1993) Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression. J Invest Dermatol 100:366-72
12. Ortiz-Urda S, Garcia J, Green CL, Chen L, Lin Q, Veitch DP et al. (2005) Type VII collagen is required for Ras-driven human epidermal tumorigenesis. Science 307:1773-6
13. Parrish EP, Steart PV, Garrod DR, Weller RO (1987) Antidesmosomal monoclonal antibody in the diagnosis of intracranial tumours. J Pathol 153:265-73
14. Rheinwald JG (1989) Methods for Clonal Growth and Serial Cultivation of Normal Human Epidermal Keratinocytes and Mesothelial Cells. Oxford: IRL Press, 81-94
15. Uitto J, Chung-Honet LC, Christiano AM (1992) Molecular biology and pathology of type VII collagen. Exp Dermatol 1:2-11
16. Varki R, Sadowski S, Uitto J, Pfendner E (2007) Epidermolysis bullosa. II. Type VII collagen mutations and phenotype/genotype correlations in the dystrophic subtypes. J Med Genet 44:181-92
17. Whittock NV, Ashton GH, Mohammedi R, Mellerio JE, Mathew CG, Abbs SJ et al. (1999) Comparative mutation detection screening of the type VII collagen gene (COL7A1) using the protein truncation test, fluorescent chemical cleavage of mismatch, and conformation sensitive gel electrophoresis. J Invest Dermatol 113:673-86